These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2683226)

  • 41. Complex mixtures of air pollutants: characterizing the cancer risk of polycyclic organic matter.
    Lewtas J
    Environ Health Perspect; 1993 Apr; 100():211-8. PubMed ID: 8354169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reassessment of MTBE cancer potency considering modes of action for MTBE and its metabolites.
    Bogen KT; Heilman JM
    Crit Rev Toxicol; 2015; 45 Suppl 1():1-56. PubMed ID: 26414780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of an oral cancer slope factor for Aroclor 1268.
    Warren DA; Kerger BD; Britt JK; James RC
    Regul Toxicol Pharmacol; 2004 Aug; 40(1):42-53. PubMed ID: 15265605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contemporary trends in in vivo and in vitro testing of chemical carcinogens.
    Slamenová D
    Neoplasma; 2001; 48(6):425-34. PubMed ID: 11949832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic activity profiles in the testing and evaluation of chemical mixtures.
    Waters MD; Claxton LD; Stack HF; Brady AL; Graedel TE
    Teratog Carcinog Mutagen; 1990; 10(2):147-64. PubMed ID: 1973853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The genotoxicity of ambient outdoor air, a review: Salmonella mutagenicity.
    Claxton LD; Matthews PP; Warren SH
    Mutat Res; 2004 Nov; 567(2-3):347-99. PubMed ID: 15572287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. National Particle Component Toxicity (NPACT) initiative report on cardiovascular effects.
    Vedal S; Campen MJ; McDonald JD; Larson TV; Sampson PD; Sheppard L; Simpson CD; Szpiro AA
    Res Rep Health Eff Inst; 2013 Oct; (178):5-8. PubMed ID: 24377210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implications of chemical mixtures in public health practice.
    de Rosa CT; El-Masri HA; Pohl H; Cibulas W; Mumtaz MM
    J Toxicol Environ Health B Crit Rev; 2004; 7(5):339-50. PubMed ID: 15371239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A proposed framework for assessing risk from less-than-lifetime exposures to carcinogens.
    Felter SP; Conolly RB; Bercu JP; Bolger PM; Boobis AR; Bos PM; Carthew P; Doerrer NG; Goodman JI; Harrouk WA; Kirkland DJ; Lau SS; Llewellyn GC; Preston RJ; Schoeny R; Schnatter AR; Tritscher A; van Velsen F; Williams GM
    Crit Rev Toxicol; 2011 Jul; 41(6):507-44. PubMed ID: 21591905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro cell transformation assays for an integrated, alternative assessment of carcinogenicity: a data-based analysis.
    Benigni R; Bossa C; Tcheremenskaia O
    Mutagenesis; 2013 Jan; 28(1):107-16. PubMed ID: 23132285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluating heterogeneity in indoor and outdoor air pollution using land-use regression and constrained factor analysis.
    Levy JI; Clougherty JE; Baxter LK; Houseman EA; Paciorek CJ;
    Res Rep Health Eff Inst; 2010 Dec; (152):5-80; discussion 81-91. PubMed ID: 21409949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BALB/c 3T3 cell transformation assay for the prediction of carcinogenic potential of chemicals and environmental mixtures.
    Mascolo MG; Perdichizzi S; Rotondo F; Morandi E; Guerrini A; Silingardi P; Vaccari M; Grilli S; Colacci A
    Toxicol In Vitro; 2010 Jun; 24(4):1292-300. PubMed ID: 20226850
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analytical methods in bioassay-directed investigations of mutagenicity of air particulate material.
    Marvin CH; Hewitt LM
    Mutat Res; 2007; 636(1-3):4-35. PubMed ID: 17468041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fundamental changes to EPA's research enterprise: the path forward.
    Anastas PT
    Environ Sci Technol; 2012 Jan; 46(2):580-6. PubMed ID: 22216884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanistic data and cancer risk assessment: the need for quantitative molecular endpoints.
    Preston RJ
    Environ Mol Mutagen; 2005; 45(2-3):214-21. PubMed ID: 15645441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A discussion of the U.S. EPA methodology for determining Water Quality Standards (WQS).
    Burmaster DE; von Stackelberg KE
    Qual Assur; 1992 Jun; 1(3):192-206. PubMed ID: 1344674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The U.S. Environmental Protection Agency's inhalation RfD methodology: risk assessment for air toxics.
    Jarabek AM; Menache MG; Overton JH; Dourson ML; Miller FJ
    Toxicol Ind Health; 1990 Oct; 6(5):279-301. PubMed ID: 1670284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Organizational components and structural features of EPA's new Human Exposure Research Program.
    Akland GG
    J Expo Anal Environ Epidemiol; 1991 Apr; 1(2):129-41. PubMed ID: 1824314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of risks posed by combustor emissions.
    Rice G; Swartout J; Brady-Roberts E; Reisman D; Mahaffey K; Lyon B
    Drug Chem Toxicol; 1999 Feb; 22(1):221-40. PubMed ID: 10189581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transplacental exposure to environmental carcinogens: Association with childhood cancer risks and the role of modulating factors.
    Fucic A; Guszak V; Mantovani A
    Reprod Toxicol; 2017 Sep; 72():182-190. PubMed ID: 28624605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.